R&D | June 10, 2026
FDA greenlights Lilly’s EBGLYSS for ultra-low-frequency dosing in eczema breakthrough
The move makes EBGLYSS the only therapy offering as few as six maintenance injections per year
The move makes EBGLYSS the only therapy offering as few as six maintenance injections per year
Preclinical CRO strengthens leadership team with key executive appointments as it scales its human tissue-based drug discovery platform
The company said data from multiple VESPER studies show the peptide delivered meaningful weight loss, favorable tolerability, and the possibility of a first-in-class monthly injection format
The collaboration will foster joint research initiatives, scientific knowledge exchange, and innovation
Based on the cumulative data from ACHIEVE-1 through ACHIEVE-5, Lilly plans to submit orforglipron for FDA approval for the treatment of type 2 diabetes by the end of the second quarter
Dengue, a mosquito-borne viral disease, is emerging as a growing public health threat across Africa
The webinar on World Environment Day brought together scientists, policymakers, industry representatives, and researchers to discuss the role of biotech and biomanufacturing in addressing climate change and advancing sustainable development
Targeting deadly drug-resistant acinetobacter infections
The ventilator features a high-performance turbine capable of delivering up to 240 L/min peak flow
Juneja brings more than three decades of experience in pharmaceutical sales and marketing
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
